Skip to content

A Comparative study between two drugs which will be used as an adjuvent in spinal anaesthetic drug for patients undergoing a kidney stone removal surgery.

Comparison of dexmedetomidine and fentanyl as an adjuvent to 0.5 % isobaric levobupivacaine in thoracic segmental spinal anaesthesia for patients undergoing Percutaeneous Nephrolithotomy. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099641
Enrollment
50
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney Health Condition 2: N20-N23- Urolithiasis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

Dr Swapnali Sarjerao Suryawanshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients willing to sign informed consent for undergoing elective thoracic segmental spinal anaesthesia 2)Patients above 18 years and below 60 years of age 3)Patients belonging to American Society of Anaesthesiologists physical status I, II and III

Exclusion criteria

Exclusion criteria: 1)Patients contraindicated for spinal anaesthesia 2)Patients with known allergy, sensitivity or any other form of reaction to the study drug 3)Pregnant or lactating patients or patients presenting for emergency surgeries

Design outcomes

Primary

MeasureTime frame
To compare the effect of addition of two adjuvent drugs Dexmedetomidine and Fentanyl in Isobaric Levobupivacaine in thoracic segmental spinal anaesthesia in patients undergoing Percutaeneous Nephrolithotomy on haemodynamic parameters, onset and duration of motor and sensory block, duration of analgesia and perioperative complicationsTimepoint: To note the effect every 5 minutes for first 15 minutes then every 30 minutes till the end of surgery for next 5 hours

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Swapnali Sarjerao Suryawanshi

Parul Institute of Medical Sciences and Research

sapusurya07618@gmail.com8780981816

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026